| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
Fig. 1. Design of the study. *Gastrointestinal cancer patients with known metastatic disease at the time of diagnosis were only randomized between IS and SC. °Erroneous diagnosis (N = 2), delay of more than 3 months from diagnosis to inclusion (N = 1), and dementia (N = 1).
Patients who were under medical investigation for a suspected breast cancer were informed that GR would be an option only if surgery confirmed a cancer diagnosis.
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |